Replimune REPL
NASDAQ REPL
$15.02 -0.27 (-1.77%)
As of: Sep 4, 2026 · 2:19 PM EDT

Replimune (REPL) Assets Average (2018 - 2026)

Replimune (REPL) posted Assets Average of $333.0 million for Q1 2026, down 7.89% sequentially from $361.5 million in Q4 2025, and down 42.34% YoY from $577.5 million in Q1 2025.

Analysis

Replimune (REPL) Assets Average (2018 - 2026) Analysis & Trends

Replimune has reported Assets Average for 9 years, with the latest figure at $333.0 million in Q1 2026.

  • Quarterly Assets Average fell 42.34% year-over-year to $333.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $333.0 million (down 42.34% YoY) and the FY2026 annual result came in at $441.9 million, down 14.95% from the prior year.
  • Assets Average retreated to $333.0 million in Q1 2026 per REPL's latest filing, from $361.5 million in the prior quarter.
  • Over five years, Assets Average peaked at $662.6 million in Q1 2023 and troughed at $333.0 million in Q1 2026.
  • A 5-year average of $509.3 million and a median of $511.3 million in 2024 frame the typical range for Assets Average.
  • The sharpest annual moves came in 2023 and 2026: Assets Average surged 40.01% in 2023, then plunged 42.34% in 2026.
  • Over 5 years, Assets Average stood at $557.3 million in 2022, then dropped by 1.73% to $547.7 million in 2023, then gained by 0.59% to $550.9 million in 2024, then sank by 34.38% to $361.5 million in 2025, then retreated by 7.89% to $333.0 million in 2026.
  • According to Business Quant data, Assets Average over the past three periods registered $333.0 million, $361.5 million, and $429.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Vertex Pharmaceuticals 138.92 Bn 131.07 Bn 2.84 Bn 26.95 Bn
2 Regeneron Pharmaceuticals 85.55 Bn 77.56 Bn 3.93 Bn 41.30 Bn
3 Argenx Se 63.55 Bn 58.37 Bn 1.37 Bn -
4 Moderna 58.26 Bn 53.13 Bn 52.00 Mn 11.22 Bn
5 Revolution Medicines 44.08 Bn 44.08 Bn - 3.29 Bn
6 BeOne Medicines 39.98 Bn 34.89 Bn 1.53 Bn 8.86 Bn
7 Alnylam Pharmaceuticals 35.32 Bn 32.01 Bn 992.69 Mn 5.34 Bn
8 Royalty Pharma 28.42 Bn 27.59 Bn - 19.82 Bn
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn 2.09 Bn
10 Replimune 1.45 Bn 1.45 Bn - 292.42 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 292.42 Mn
Mar 31, 2026 332.99 Mn
Dec 31, 2025 361.52 Mn
Sep 30, 2025 429.48 Mn
Jun 30, 2025 510.42 Mn
Mar 31, 2025 577.48 Mn
Dec 31, 2024 550.92 Mn
Sep 30, 2024 516.58 Mn
Jun 30, 2024 511.34 Mn
Mar 31, 2024 510.33 Mn
Dec 31, 2023 547.66 Mn
Sep 30, 2023 583.14 Mn
Jun 30, 2023 625.24 Mn
Mar 31, 2023 662.57 Mn
Dec 31, 2022 557.32 Mn
Sep 30, 2022 447.76 Mn
Jun 30, 2022 460.31 Mn
Mar 31, 2022 473.24 Mn
Dec 31, 2021 494.37 Mn
Sep 30, 2021 513.59 Mn